When was Latch founded?

Latch was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Latch located?

Latch is headquartered in San Francisco, United States.

Who is the current CEO of Latch?

Alfredo Andere of Latch. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Latch have?

As of May 31, 2026, the latest employee count at Latch is 37.

Is Latch a funded company?

Latch is a funded company, having raised a total of $33M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 04, 2021.

When was the latest funding round of Latch?

Latch's latest funding was a $***** Series A round on Jun 02, 2022, with participation from 6 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $2.13B in funding in 2026 to date.

Where does Latch rank among its competitors?

Latch ranks 4th amongst 511 active competitors, of which 78 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Genialis, which secured $700K in Dec, 2025.

Who are the top competitors of Latch?

Latch's top competitors include Benchling, Helix and Congenica. Among them, Genialis secured the most recent funding round in December, 2025.

Latch - 2026 Company Profile, Team, Funding & Competitors

Latch is a series A company based in San Francisco (United States), founded in 2021 by Alfredo Andere, Kyle Giffin and Kenny Workman. It operates as a Provider of a web-based platform for genomic bioinformatics. Latch has raised $33M in funding from Lux Capital and Coatue. The company has 511 active competitors, including 78 funded and 37 that have exited. Its top competitors include companies like Benchling, Helix and Congenica.

Company Details

Provider of a web-based platform for genomic bioinformatics. The company offers a biocomputing platform that enables biologists to analyze CRISPR data, and creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery.

Website: latch.bio
Social
Email ID: *****@latch.bio

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series A

Total Funding

$33M in 2 rounds

Latest Funding Round

Series A, Jun 02, 2022, $*****

Investors

Lux Capital & 8 more

Ranked

4^th among 511 active competitors

Employee Count

37 as on May 31, 2026

Similar Companies

Benchling & 673 more

View Latch's full profile

Latch has raised a total funding of $33M over 2 rounds. Its first funding round was on Oct 04, 2021. Its latest funding round was a Series A round on Jun 02, 2022 for $*****. 6 investors participated in its latest round. Latch has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Latch:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 02, 2022	5615423	Series A	4202721	3897311	3786027	4115981
Oct 04, 2021	8303120	Seed	1384830	1412494	Lux Capital	Fifty Years & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Latch's funding rounds and investors

The founders of Latch are Alfredo Andere, Kyle Giffin and Kenny Workman. Alfredo Andere is the CEO of Latch.

Here are the details of Latch's key team members:

Alfredo Andere: Co-Founder & CEO of Latch. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Kyle Giffin: Co-Founder of Latch.
Kenny Workman: Co-Founder and CTO of Latch.

View details of Latch's Founder profiles and Board Members

Latch's employee count trend

Latch has 37 employees as of May 26. Here is Latch's employee count trend over the years:

Uncover Latch's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Latch include Benchling, Helix and Congenica. Here is the list of Top 10 competitors of Latch, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Menlo Ventures & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Warburg Pincus & 12 others	71/100
3rd	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	Puhua Capital, IDO Investments & 39 others	62/100
4th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	General Catalyst, Hummingbird Ventures & 7 others	59/100
5th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Supernova Invest & 7 others	57/100
6th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
7th	NextBio 2004, Santa Clara (United States), Acqui-Hired	NextBio provides a platform to aggregate and interpret large quantities of genomic data for research and clinical applications.	$28.3M	Rising Tide Fund, RONA Holdings & 6 others	56/100
8th	Genialis 2015, Boston (United States), Series A	Developer of end-to-end bioinformatics software solutions	$16M	Taiwania Capital, Redalpine & 9 others	56/100
9th	Genedata 1997, Basel (Switzerland), Acquired	Software solutions for drug discovery, industrial biotechnology, and life science research	-	Novartis Venture Fund, Alta Partners & 1 others	56/100
10th	SCIEX 1970, Boston (United States), Acquired	Provider of scientific instrumentation, software, and services for the life science industry	-	Europa	54/100